Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain
Fuente:
Redalyc
Guardado en:
| Autor principal: | Santiago Moreno Guillén |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Sociedad Española de Farmacia Hospitalaria
2017
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis
por: Juan Carlos Alzate Angel
Publicado: (2017)
por: Juan Carlos Alzate Angel
Publicado: (2017)
Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort
por: Inés Suárez‐García, et al.
Publicado: (2025)
por: Inés Suárez‐García, et al.
Publicado: (2025)
Factors associated with adherence in HIV patients
por: A. Arrondo Velasco
Publicado: (2009)
por: A. Arrondo Velasco
Publicado: (2009)
The OCLC Network: Its Architecture, Application, and Operation.
por: Learn, Larry L., et al.
Publicado: (1988)
por: Learn, Larry L., et al.
Publicado: (1988)
Psychosocial Adjustment to Illness among HIV-Positive People from Buenos Aires, Argentina
por: Carlos Jesús Canova Barrios
Publicado: (2022)
por: Carlos Jesús Canova Barrios
Publicado: (2022)
Sociodemographic and pharmacoepidemiological profile of people on antiretroviral therapy in the coast of the state of Paraná
por: Marlon Silva
Publicado: (2022)
por: Marlon Silva
Publicado: (2022)
Short and long period optimization of drug doses in the treatment of AIDS
por: Marco A. L. Caetano
Publicado: (2002)
por: Marco A. L. Caetano
Publicado: (2002)
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series
por: Yanyun Dou, et al.
Publicado: (2024)
por: Yanyun Dou, et al.
Publicado: (2024)
Real‐world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV‐1 aged over 50 years who are virologically suppressed
por: C. Piñeiro, et al.
Publicado: (2024)
por: C. Piñeiro, et al.
Publicado: (2024)
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir
por: Pierluigi Francesco Salvo, et al.
Publicado: (2025)
por: Pierluigi Francesco Salvo, et al.
Publicado: (2025)
The Impact of Adding Retrospective Conversion Holdings to OCLC on Interlibrary Loan Lending.
por: McCartney, Elizabeth J.
Publicado: (1989)
por: McCartney, Elizabeth J.
Publicado: (1989)
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies
por: C. Katlama, et al.
Publicado: (2024)
por: C. Katlama, et al.
Publicado: (2024)
Techno-economic evaluation of a chromic wastewater treatment plant proposal
por: Amaury Pérez Sánchez
Publicado: (2022)
por: Amaury Pérez Sánchez
Publicado: (2022)
Lighting Design--A Missed Opportunity
Publicado: (1978)
Publicado: (1978)
The Linked Systems Project: Progress, Promise, Realities.
por: McCoy, Richard W.
Publicado: (1986)
por: McCoy, Richard W.
Publicado: (1986)
Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1
por: Itziar Oyagüez
Publicado: (2009)
por: Itziar Oyagüez
Publicado: (2009)
Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele
por: Noemí Pérez Prior
Publicado: (2009)
por: Noemí Pérez Prior
Publicado: (2009)
Exploring the experiences and perspectives of Iraqi healthcare providers on the challenges and determinants of HIV management: a qualitative study
por: Talabani, Shlova Najim, et al.
Publicado: (2025)
por: Talabani, Shlova Najim, et al.
Publicado: (2025)
A Cost Model for Preservation: The Columbia University Libraries' Approach.
por: Harris, Carolyn, et al.
Publicado: (1991)
por: Harris, Carolyn, et al.
Publicado: (1991)
Cost-reduction analysis for oral versus intravenous Áudarabine (BeneÁur®) in Spain
por: Julio Delgado
Publicado: (2009)
por: Julio Delgado
Publicado: (2009)
Bibliographic Control of Microform Sets: Some Recent Accomplishments and Concerns.
por: Leung, Shirley W.
Publicado: (1989)
por: Leung, Shirley W.
Publicado: (1989)
Federal Documents in the Online Catalog: Problems, Options, and the Future.
por: Swanbeck, Jan
Publicado: (1985)
por: Swanbeck, Jan
Publicado: (1985)
THE FACES OF VULNERABILITY - WOMEN, MOTHER, HIV POSITIVE: REFLECTIONS ON WOMEN HEALTH NURSING
por: Isabel Catarina Correia Braga
Publicado: (2010)
por: Isabel Catarina Correia Braga
Publicado: (2010)
Blood pressure and metabolic outcomes after efavirenz‐ or dolutegravir‐based therapy started in acute HIV infection
por: Phillip Chan, et al.
Publicado: (2025)
por: Phillip Chan, et al.
Publicado: (2025)
Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients
por: María C. Cano Salas
Publicado: (2024)
por: María C. Cano Salas
Publicado: (2024)
A bootstrapped neural network model applied to prediction of the biodegradation rate of reactive Black 5 dye
por: Kleber Rogério Moreira Prado
Publicado: (2013)
por: Kleber Rogério Moreira Prado
Publicado: (2013)
Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná
por: Bárbara Thaís Poliselo de Sá
Publicado: (2022)
por: Bárbara Thaís Poliselo de Sá
Publicado: (2022)
Factors associated to the control of viral load in HIV positive patients
por: Leticia Ferraz Pamplona
Publicado: (2021)
por: Leticia Ferraz Pamplona
Publicado: (2021)
Costing Methods: meta-analysis of articles presented in the Brazilian Congress of Costs over the 1994-2010 period
por: Márcia Zanievicz
Publicado: (2013)
por: Márcia Zanievicz
Publicado: (2013)
Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain
por: Josep M. Llibre, et al.
Publicado: (2024)
por: Josep M. Llibre, et al.
Publicado: (2024)
Four Online Database Vendors: An Evaluation and Cost Analysis of Their Cataloging Support Services.
por: Chan, Anthony P.
Publicado: (1990)
por: Chan, Anthony P.
Publicado: (1990)
A Comparison of OCLC, WLN, and RLIN for Public Services: A 1985 Update.
por: Hirst, Donna L., et al.
Publicado: (1986)
por: Hirst, Donna L., et al.
Publicado: (1986)
OCLC Utilization in Health Sciences Libraries. CE 35, Revised Edition.
por: Armes, Patti
Publicado: (1980)
por: Armes, Patti
Publicado: (1980)
School Library Technology.
por: Berglund, Patricia
Publicado: (1986)
por: Berglund, Patricia
Publicado: (1986)
Implementation of a non-conventional method to characterize voltage sags and swells
por: Jorge Enrique Celis-Montero
Publicado: (2016)
por: Jorge Enrique Celis-Montero
Publicado: (2016)
Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region
por: Juan Manuel De La Hoz
Publicado: (2014)
por: Juan Manuel De La Hoz
Publicado: (2014)
Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study
por: Shobna Sawry, et al.
Publicado: (2024)
por: Shobna Sawry, et al.
Publicado: (2024)
Pretreatment HIV Drug-resistance Surveillance as a Tool for Monitoring and Control of the HIV/AIDS Epidemic in Cuba
por: Liuber Y. Machado-Zaldívar
Publicado: (2021)
por: Liuber Y. Machado-Zaldívar
Publicado: (2021)
IMUNOPATOLOGIA DA INFECÇÃO PELO HIV/AIDS: MECANISMOS, CONTRADIÇÕES E CONTROVÉRSIAS
por: Fernando Samuel Sion
Publicado: (2011)
por: Fernando Samuel Sion
Publicado: (2011)
Cost minimisation analysis for darbepoetin alpha vs epoetin alpha in chronic kidney disease patients on haemodialysis
por: C. Cuesta Grueso
Publicado: (2010)
por: C. Cuesta Grueso
Publicado: (2010)
Ejemplares similares
-
Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis
por: Juan Carlos Alzate Angel
Publicado: (2017) -
Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort
por: Inés Suárez‐García, et al.
Publicado: (2025) -
Factors associated with adherence in HIV patients
por: A. Arrondo Velasco
Publicado: (2009) -
The OCLC Network: Its Architecture, Application, and Operation.
por: Learn, Larry L., et al.
Publicado: (1988) -
Psychosocial Adjustment to Illness among HIV-Positive People from Buenos Aires, Argentina
por: Carlos Jesús Canova Barrios
Publicado: (2022)